Feature | November 13, 2013

SCAI Highlights Radial Access Best Practices

More interventional cardiologists are performing transradial angioplasty, sparking need for guidance to prevent complications and optimize patient care

cath lab radial access SCAI
November 13, 2013 — The Society for Cardiovascular Angiography and Interventions (SCAI) published a first-of-its-kind paper defining best practices for the use of the transradial approach for diagnosing and treating blocked heart arteries. Published online in Catheterization and Cardiovascular Interventions (CCI), the recommendations aim to ensure high-quality patient care as transradial access becomes the preferred technique for catheter-based procedures. Studies show a decreased risk for bleeding and vascular complications, increased patient satisfaction and reduced costs when the transradial approach is used.
  
“While there are a number of benefits to transradial over transfemoral approaches, there are risks associated with any procedure. By emphasizing proper training and highlighting best practices, we aim to ensure that patients receive the advantages of this approach while minimizing any potential complications,” said Sunil Rao, M.D., FSCAI, associate professor of medicine, Duke University and lead author of the consensus statement.
 
In developing this statement, SCAI focused on three core areas to guide physicians:
 
Best practices for avoiding blocked blood flow to the radial (wrist) artery:
Patients should be assessed prior to discharge and at the first post-procedure visit to avoid the potential for radial artery occlusion (RAO), where blood flow to the artery is blocked. Extra care also should be taken to ensure patients receive all relevant strategies for prevention of RAO.
 
Best practices for reducing potential radiation exposure to patient and operators:
To reduce the risk of exposure to radiation during a transradial procedure, the patient’s accessed arm should be placed next to his or her torso. Additional extension tubing should be used and operators should be cognizant of safe radiation protocols.
 
Best practices for physicians transitioning to the transradial approach when treating heart attack:
Studies have shown benefits when patients suffering a heart attack undergo angioplasty via the wrist.  Steps must be taken to ensure physicians have mastered the technique before performing emergency cases routinely from the wrist. This learning process includes understanding when to revert to access through the femoral (groin) artery and how to ensure that using the radial approach does not result in delayed treatment or increased door-to-balloon time.
  
Fore more information: www.scai.org

Related Content

Synergy stent, abluminal polymer DES, bioresorbable polymer DES, bioresorbable polymer metallic stent

The Synergy stent is the first FDA cleared drug-eluting stent to use a bioresorbable polymer drug carrier. When the polymer dissolves after about four months, the devices become a bare metal stent. The technology is supposed to reduce the rate of late stent thrombosis due to vessel inflammation caused by durable polymers.

Feature | Stents Bioresorbable| January 17, 2017 | Dave Fornell
One of the big advancements in drug-eluting stent (DES) technology has been the development of bioresorbable polymers
Medtronic, CoreValve Evolut R TAVR system, U.S. IDE Study, TCT 2016
News | Heart Valve Technology| November 03, 2016
Medtronic plc unveiled new clinical data showing that patients treated with the self-expanding CoreValve Evolut R...
congenital heart patients, cardiac cath lab, anesthesia sedation practices, joint document, SCAI, SPA, CCAS
News | Congenital Heart| November 03, 2016
The Society for Cardiovascular Angiography and Interventions (SCAI), the Society for Pediatric Anesthesia (SPA) and the...
open-heart surgery, PCI, percutaneous coronary intervention, NOBLE trial, left main coronary artery disease, LMCAD, TCT 2016
News | Cardiovascular Surgery| November 03, 2016
Coronary artery bypass (CABG) surgery is the standard treatment for revascularization in patients with left main...
SENTINEL trial, transcatheter embolic protection, TCEP, TAVR, stroke, TCT 2016
News | Embolic Protection Devices| November 03, 2016
An international study has found that transcatheter cerebral embolic protection (TCEP) is safe, provides effective...
News | Drug-Eluting Balloons| November 03, 2016
The Spectranetics Corp. announced that it has submitted to the U.S. Food & Drug Administration (FDA) its Pre-Market...
RESPECT trial, Amplatzer PFO Occluder, St. Jude Medical, TCT 2016
News | Structural Heart Occluders| November 02, 2016
St. Jude Medical Inc. announced the long-term data from RESPECT, a landmark trial, during a First Report session at the...
Medtronic, Resolute Integrity DES, drug-eluting stent, BIO-RESORT study, TCT 2016
News | Stents Drug Eluting| November 02, 2016
Investigators recently unveiled clinical data from the independent BIO-RESORT study, representing the first all-comers...
Medtronic, Harmony TPV, transcatheter pulmonary valve, clinical study results, TCT 2016
News | Heart Valve Technology| November 02, 2016
Medtronic plc recently announced new clinical data for the Harmony Transcatheter Pulmonary Valve (TPV) from its early...
St. Jude Medical, Amplatzer PFO Occluder, FDA approval, U.S. launch
Technology | Structural Heart Occluders| November 02, 2016
St. Jude Medical Inc. announced this week the U.S. Food and Drug Administration (FDA) approval and launch of the...
Overlay Init